Indivior assigns new director Kingsley to Audit & Risk and Compensation committees

Indivior Pharmaceuticals, Inc.

Stuart A. (Tony) Kingsley appointed non-executive director effective July 1, 2025.
He will serve on the Audit & Risk Committee and the Compensation Committee.
Appointment previously disclosed; amendment adds committee assignment details.

item 5.02

Indivior Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-25-037425

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.